Delta Lloyd NV Buys 3,453 Shares of Omega Healthcare Investors, Inc. (OHI)

Delta Lloyd NV increased its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 7.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 48,605 shares of the real estate investment trust’s stock after buying an additional 3,453 shares during the period. Delta Lloyd NV’s holdings in Omega Healthcare Investors were worth $1,604,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Norges Bank acquired a new position in Omega Healthcare Investors during the fourth quarter worth approximately $42,945,000. Allianz Asset Management AG increased its position in Omega Healthcare Investors by 4.9% in the fourth quarter. Allianz Asset Management AG now owns 79,243 shares of the real estate investment trust’s stock worth $2,477,000 after buying an additional 3,732 shares during the period. Advisors Asset Management Inc. increased its position in Omega Healthcare Investors by 15.0% in the first quarter. Advisors Asset Management Inc. now owns 74,345 shares of the real estate investment trust’s stock worth $2,453,000 after buying an additional 9,715 shares during the period. Howe & Rusling Inc. increased its position in Omega Healthcare Investors by 19.5% in the first quarter. Howe & Rusling Inc. now owns 232,679 shares of the real estate investment trust’s stock worth $7,676,000 after buying an additional 37,905 shares during the period. Finally, Capstone Asset Management Co. increased its position in Omega Healthcare Investors by 5.3% in the first quarter. Capstone Asset Management Co. now owns 18,503 shares of the real estate investment trust’s stock worth $610,000 after buying an additional 930 shares during the period. 75.54% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Omega Healthcare Investors, Inc. (OHI) opened at 32.93 on Friday. The stock has a market capitalization of $6.48 billion, a price-to-earnings ratio of 15.44 and a beta of 0.55. The stock’s 50 day moving average is $32.36 and its 200 day moving average is $32.14. Omega Healthcare Investors, Inc. has a 12-month low of $28.11 and a 12-month high of $38.09.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings data on Wednesday, May 3rd. The real estate investment trust reported $0.88 EPS for the quarter, topping the Zacks’ consensus estimate of $0.86 by $0.02. The firm had revenue of $231.74 million during the quarter, compared to the consensus estimate of $197.55 million. Omega Healthcare Investors had a return on equity of 9.95% and a net margin of 45.16%. The firm’s revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the business earned $0.83 EPS. Equities research analysts forecast that Omega Healthcare Investors, Inc. will post $1.99 EPS for the current fiscal year.

WARNING: This piece was first published by Transcript Daily and is the property of of Transcript Daily. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://transcriptdaily.com/2017/06/17/omega-healthcare-investors-inc-ohi-shares-bought-by-delta-lloyd-nv-updated-updated.html.

A number of analysts have recently weighed in on the stock. Jefferies Group LLC restated a “hold” rating and issued a $33.00 price target on shares of Omega Healthcare Investors in a report on Friday, May 12th. Zacks Investment Research cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Tuesday, February 21st. Finally, Vetr cut shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating and set a $32.50 target price for the company. in a research note on Monday, April 17th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the stock. The company currently has an average rating of “Hold” and an average price target of $34.67.

In related news, insider Steven J. Insoft sold 87,500 shares of the company’s stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $34.00, for a total transaction of $2,975,000.00. Following the completion of the transaction, the insider now directly owns 324,076 shares in the company, valued at approximately $11,018,584. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Craig R. Callen acquired 15,000 shares of the stock in a transaction that occurred on Friday, June 2nd. The shares were bought at an average price of $31.40 per share, with a total value of $471,000.00. Following the completion of the purchase, the director now owns 18,000 shares in the company, valued at $565,200. The disclosure for this purchase can be found here. 4.54% of the stock is owned by corporate insiders.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply